GB0419176D0 - Method of treatment and compositions - Google Patents
Method of treatment and compositionsInfo
- Publication number
- GB0419176D0 GB0419176D0 GB0419176A GB0419176A GB0419176D0 GB 0419176 D0 GB0419176 D0 GB 0419176D0 GB 0419176 A GB0419176 A GB 0419176A GB 0419176 A GB0419176 A GB 0419176A GB 0419176 D0 GB0419176 D0 GB 0419176D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0419176A GB0419176D0 (en) | 2004-08-27 | 2004-08-27 | Method of treatment and compositions |
MX2007002169A MX2007002169A (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases. |
AU2005276231A AU2005276231A1 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases |
PCT/GB2005/003350 WO2006021803A2 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
JP2007528987A JP5117189B2 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases |
EP05775408A EP1799230B1 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
US11/660,249 US20080125404A1 (en) | 2004-08-27 | 2005-08-25 | Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune Diseases |
CA002576159A CA2576159A1 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
PL05775408T PL1799230T3 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
CN2005800370898A CN101048160B (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
ES05775408T ES2403558T3 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases |
US13/464,362 US8809350B2 (en) | 2004-08-27 | 2012-05-04 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0419176A GB0419176D0 (en) | 2004-08-27 | 2004-08-27 | Method of treatment and compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0419176D0 true GB0419176D0 (en) | 2004-09-29 |
Family
ID=33104750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0419176A Ceased GB0419176D0 (en) | 2004-08-27 | 2004-08-27 | Method of treatment and compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0419176D0 (en) |
-
2004
- 2004-08-27 GB GB0419176A patent/GB0419176D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1791791T1 (en) | Methods and compositions for treatment of water | |
GB2423928B (en) | Methods and compositions for treating pain | |
GB2414666B (en) | Sanitizing composition and method of preparation | |
IL178996A0 (en) | Thienopyridinone compounds and methods of treatment | |
EP1737482A4 (en) | Compositions and methods for treating diseases | |
ZA200704677B (en) | Compositions and methods for the treatment of autism | |
IL179931A0 (en) | Compositions and methods for treatment of cardiovascular disease | |
IL182436A0 (en) | Thienopyridinone compounds and methods of treatment | |
IL174627A0 (en) | Compositions and methods for treatment of burns | |
HK1121952A1 (en) | Methods and compositions for treating conditions | |
EP1696910A4 (en) | Compositions and methods for treatment of fibrosis | |
EP1765260A4 (en) | Sanitizing composition and method of preparation | |
HK1109576A1 (en) | Aequorin-containing compositions and methods of using same | |
EP1786265A4 (en) | Novel compositions and methods of treatment | |
ZA200709024B (en) | Method of well treatment and construction | |
GB0324523D0 (en) | Compositions and methods of treatment | |
EP1720563A4 (en) | Methods and compositions for the treatment of inflammation | |
EP1824462A4 (en) | Composition and method for the treatment of tauopathies | |
EP1784193A4 (en) | Composition and method for treatment and prevention of atherosclerosis | |
GB0520930D0 (en) | Composition and method of use | |
GB0419175D0 (en) | Method of treatment and compositions | |
GB0504657D0 (en) | Compositions and methods of treatment | |
GB0419176D0 (en) | Method of treatment and compositions | |
AU2004900546A0 (en) | Method of Treatment and Composition | |
EP1616020A4 (en) | Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |